Azithromycin in the treatment of COVID-19: a review

D Echeverría-Esnal, C Martin-Ontiyuelo… - Expert review of anti …, 2021 - Taylor & Francis
Introduction SARS-CoV-2 is a novel virus that causes coronavirus disease-19 (COVID-19).
Antiviral and immunomodulatory agents have been proposed as potential treatments …

Azithromycin in viral infections

ME Oliver, TSC Hinks - Reviews in medical virology, 2021 - Wiley Online Library
Azithromycin (AZM) is a synthetic macrolide antibiotic effective against a broad range of
bacterial and mycobacterial infections. Due to an additional range of anti‐viral and anti …

Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline

CL Daley, JM Iaccarino, C Lange… - Clinical Infectious …, 2020 - academic.oup.com
Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of
which can produce disease in humans of all ages and can affect both pulmonary and …

ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

I Martin-Loeches, A Torres, B Nagavci, S Aliberti… - Intensive care …, 2023 - Springer
Purpose Severe community-acquired pneumonia (sCAP) is associated with high morbidity
and mortality, and whilst European and non-European guidelines are available for …

Update on the adverse effects of antimicrobial therapies in community practice

S Mohsen, JA Dickinson, R Somayaji - Canadian Family Physician, 2020 - cfp.ca
Objective To gather information about antibiotic side effects to be used as a reference and
learning resource for prescribing physicians. Quality of evidence A search of websites of …

[HTML][HTML] Chronic cough: new insights and future prospects

A Morice, P Dicpinigaitis, L McGarvey… - European Respiratory …, 2021 - Eur Respiratory Soc
Chronic cough is defined in adults as a cough that lasts for≥ 8 weeks. When it proves
intractable to standard-of-care treatment, it can be referred to as refractory chronic cough …

Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides

É Kocsmár, GM Buzás, I Szirtes, I Kocsmár… - Nature …, 2021 - nature.com
Clarithromycin is a macrolide antibiotic widely used for eradication of Helicobacter pylori
infection, and thus resistance to this antibiotic is a major cause of treatment failure. Here, we …

Macrolides: From toxins to therapeutics

KD Lenz, KE Klosterman, H Mukundan… - Toxins, 2021 - mdpi.com
Macrolides are a diverse class of hydrophobic compounds characterized by a macrocyclic
lactone ring and distinguished by variable side chains/groups. Some of the most well …

Adverse event profile during the treatment of Helicobacter pylori: a real-world experience of 22,000 patients from the European registry on H. pylori management (Hp …

OP Nyssen, A Perez-Aisa, B Tepes… - Official journal of the …, 2021 - journals.lww.com
METHODS: Systematic prospective noninterventional registry of the clinical practice of
European gastroenterologists (27 countries, 300 investigators) on the management of H …

Antimicrobial stewardship in rural and remote primary health care: a narrative review

JW Yau, SM Thor, D Tsai, T Speare… - Antimicrobial Resistance & …, 2021 - Springer
Background Antimicrobial resistance is an emerging problem worldwide and poses a
significant threat to human health. Antimicrobial stewardship programmes are being …